Targeting sphingosine kinase 1 attenuates bleomycininduced pulmonary fibrosis

FASEB Journal

Volumn 27, Issue 4, 2013, Pages 1749-1760

  Huang, Long Shuang ^a   Berdyshev, Evgeny ^a,b   Mathew, Biji ^a,b   Fu, Panfeng ^a   Gorshkova, Irina A ^a,b   He, Donghong ^a   Ma, Wenli ^a   Noth, Imre ^c   Ma, Shwu Fan ^c   Pendyala, Srikanth ^a   Reddy, Sekhar P ^a   Zhou, Tong ^a,b   Zhang, Wei ^a   Garzon, Steven A ^a   Garcia, Joe G N ^a,b   Natarajan, Viswanathan ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

S1P; S1P lyase; TGF

Indexed keywords

BLEOMYCIN; PHOSPHOTRANSFERASE INHIBITOR; SMAD2 PROTEIN; SPHINGOSINE KINASE 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG FUNCTION; LUNG PARENCHYMA; MALE; MICROARRAY ANALYSIS; MORTALITY; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL;

AGED; ANIMALS; BLEOMYCIN; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SIGNAL TRANSDUCTION; SPHINGOSINE; TRANSFORMING GROWTH FACTOR BETA;

MUS;

EID: 84875702933     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-219634     Document Type: Article

References (45)

1. King, T. E., Jr. (1998) Update in pulmonary medicine. Ann. Intern. Med. 129, 806-812.
2. Sappino, S.P., Schurch, W., and Gabbiani, G. (1990) Differentiation repertoire of fibroblastic cells: expression of cytoskeletal protein as marker of phenotypic modulations. Lab. Invest. 63, 144-161.
3. Phan, S. H. (2002) The myofibroblast in pulmonary fibrosis. Chest 122, 286S-289S.
4. Cucoranu, I., Clempus, R., Dikalova, A., Phelan, P. J., Ariyan, S., Dikalov, S., and Sorescu, D. (2005) NAD(P)H oxidase 4 mediates transforming growth factor b1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ. Res. 97, 900-907.
5. Selman, M., King, T. E., and Pardo, A. (2001) Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 134, 136-151.
6. Mouratis, M. A. and Aidinis, V. (2011) Modeling pulmonary fibrosis with bleomycin. Curr. Opin. Pulm. Med. 17, 355-361.
7. Funke, M., Zhao, Z., Xu, Y., Chun, J., and Tager, A. M. (2012) The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury. Am. J. Respir. Cell Mol. Biol. 46, 355-364.
8. Tager, A. M., LaCamera, P., Shea, B. S., Campanella, G. S., Selman, M., Zhao, Z., Polosukhin, V., Wain, J., Karimi-Shah, B. A., Kim, N. D., Hart, W. K., Pardo, A., Blackwell, T. S., Xu, Y., Chun, J., and Luster, A. D. (2008) The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat. Med. 14, 45-54.
9. Aoki, J., Inoue, A., and Okudaira, S. (2008) Two pathways for lysophosphatidic acid production. Biochim. Biophys. Acta 1781, 513-518.
10. Ghosh, M., Stewart, A., Tucker, D. E., Bonventre, J. V., Murphy, R. C., and Leslie, C. C. (2004) Role of cytosolic phospholipase A(2) in prostaglandin E(2) production by lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 30, 91-100.
11. Hla, T. (2004) Physiological and pathological actions of sphingosine 1-phosphate. Semin. Cell Dev. Biol. 15, 513-520.
12. Cencetti, F., Bernacchioni, C., Nincheri, P., Donati, C., and Bruni, P. (2010) Transforming growth factor-beta1 induces transdifferentiation of myoblasts into myofibroblasts via upregulation of sphingosine kinase-1/S1P3 axis. Mol. Biol. Cell 21, 1111-1124.
13. Shea, B. S., Brooks, S. F., Fontaine, B. A., Chun, J., Luster, A. D., and Tager, A. M. (2010) Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury. Am. J. Respir. Cell Mol. Biol. 43, 662-673.
14. Gorshkova, I., Zhou, T., Mathew, B., Jacobson, J. R., Takekoshi, D., Bhattacharya, P., Smith, B., Aydogan, B., Weichselbaum, R. R., Natarajan, V., Garcia, J. G., and Berdyshev, E. V. (2012) Inhibition of serine palmitoyltransferase delays the onset of radiation-induced pulmonary fibrosis through the negative regulation of sphingosine kinase-1 expression. J. Lipid Res. 53, 1553-1568.
15. Inage, M., Nakamura, H., Saito, H., Abe, S., Hino, T., Takabatake, N., Terashita, K., Ogura, M., Kato, S., Hosokawa, T., Sata, M., and Tomoike, H. (2009) Vesnarinone represses the fibrotic changes in murine lung injury induced by bleomycin. Int. J. Biol. Sci. 5, 304-310.
16. Ashcroft, T., Simpson, J. M., and Timbrell, V. (1988) Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41, 467-470.
17. Hübner, R. H., Gitter, W., El Mokhtari, N. E., Mathiak, M., Both, M., Bolte, H., Freitag-Wolf, S., and Bewig, B. (2008) Standardized quantification of pulmonary fibrosis in histological samples. BioTechniques 44, 507-511.
18. Vaskovsky, V. E., Kostetsky, E. Y., and Vasendin, I. M. (1975) A universal reagent for phospholipid analysis. J. Chromatogr. 114, 129-141.
19. Berdyshev, E. V., Gorshkova, I., Usatyuk, P., Kalari, S., Zhao, Y., Pyne, N. J., Pyne, S., Sabbadini, R. A., Garcia, J. G., and Natarajan, V. (2011) Intracellular S1P generation is essential for S1P-induced motility of human lung endothelial cells: role of sphingosine kinase 1 and S1P lyase. PLoS One 6, e16571.
20. Duan, S., Zhang, W., Bleibel, W. K., Cox, N. J., and Dolan, M. E. (2008) SNPinProbe-1.0: a database for filtering out probes in the Affymetrix GeneChip human exon 1.0 ST array potentially affected by SNPs. Bioinformation 2, 469-470.
21. Tusher, V. G., Tibshirani, R., and Chu, G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98, 5116-5121.
22. Kono, Y., Nishiuma, T., Nishimura, Y., Kotani, Y., Okada, T., Nakamura, S., and Yokoyama. M. (2007) Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1. Am. J. Respir. Cell Mol. Biol. 37, 395-404.
23. Hamada, K., Nagai, S., Tanaka, S., Handa, T., Shigematsu, M., Nagao, T., Mishima, M., Kitaichi, M., and Izumi, T. (2007) Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 131, 650-656.
24. Chiba, Y., Takeuchi, H., Sakai, H., and Misawa, M. (2010) SKI-II, an inhibitor of sphingosine kinase, ameliorates antigen-induced bronchial smooth muscle hyperresponsiveness, but not airway inflammation, in mice. J. Pharmacol. Sci. 114, 304-310.
25. French, K. J., Schrecengost, R. S., Lee, B. D., Zhuang, Y., Smith, S. N., Eberly, J. L., Yun, J. K., and Smith. C.D. (2003) Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res. 63, 5962-5969.
26. Khalil, N., O'Connor, R. N., Unruh, H. W., Warren, P. W., Flanders, K. C., Kemp, A., Bereznay, O. H., and Greenberg, A. H. (1991) Increased production and immunohistochemical local-ization of transforming growth factor-β in idiopathic lung fibrosis. Am. J. Respir. Cell Mol. Biol. 5, 155-162.
27. Limper, A. H., Broekelmann, T. J., Colby, T. V., Malizia, G., and McDonald, J. A. (1991) Analysis of local mRNA expression for extracellular matrix proteins and growth factors using in situ hybridization in fibroproliferative lung disorders. Chest 99, 55S-56S.
28. Bartram, U., and Speer, C. P. (2004) The role of transforming growth factor beta in lung development and disease. Chest 125, 754-765.
29. Liu, L., Carron, B., Yee, H. T., Yie, T. A., Hajjou, M., and Rom, W. (2009) Wnt pathway in pulmonary fibrosis in the bleomycin mouse model. J. Environ. Pathol. Toxicol. Oncol. 28, 99-108.
30. Liu, G., Friggeri, A., Yang, Y., Milosevic, J., Ding, Q., Thannickal, V. J., Kaminski, N., and Abraham, E. (2010) miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J. Exp. Med. 207, 1589-1597.
31. Oskouian, B., and Saba, J. (2007) Sphingosine-1-phosphate metabolism and intestinal tumorigenesis: lipid signaling strikes again. Cell Cycle 6, 522-527.
32. Milara, J., Navarro, R., Juan, G., Peiró T, Serrano, A., Ramón, M., Morcillo, E., Cortijo, J. (2012) Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition. Thorax 67, 147- 156.
33. Takuwa, N., Ohkura, S-I., Takashima, S-I., Ohtani, K., Okamoto, Y., Tanaka, T., Hirano, K., Usui, S., Wang, F., Du, W., Yoshioka, K., Banno, Y., Sasaki, M., Ichi, I., Okamura, M., Sugimoto, N., Mizugishi, K., Nakanuma, Y., Ishii, I., Takamura, M., Kaneko, S., Kojo, S., satouchi, K., Mitumori, K., Chun, J., and Takuwa, Y. (2010) S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species. Cardiovac. Res. 85, 484-493.
34. Di, A., Kawamura, T., Gao, X. P., Tang, H., Berdyshev, E., Vogel, S. M., Zhao, Y. Y., Sharma, T., Bachmaier, K., Xu, J., and Malik, A. B. (2010) A novel function of sphingosine kinase 1 suppression of JNK activity in preventing inflammation and injury. J. Biol. Chem. 285, 15848-14857.
35. Zemann, B., Urtz, N., Reuschel, R., Mechtcheriakova, D., Bornancin, F., Badegruber, R., Baumruker, T., and Billich, A. (2007) Normal neutrophil functions in sphingosine kinase type 1 and 2 knockout mice. Immunol. Lett. 109, 56-63.
36. Dhami, R., He, X., and Schuchman, E. H. (2010) Acid sphingomyelinase deficiency attenuates bleomycin-induced lung inflammation and fibrosis in mice. Cell. Physiol. Biochem. 26, 749-760.
37. Kharel, Y., Mathews, T. P., Kennedy, A. J., Houck, J. D., Macdonald, T. L., and Lynch, K. R. (2011) A rapid assay for assessment of sphingosine kinase inhibitors and substrates. Anal. Biochem. 411, 230-235.
38. Gao, P., Peterson, Y. K., Smith, R. A., and Smith, C. D. (2012) Characterization of isoenzymes-selective inhibitors of human sphingosine kinases. PLoS ONE 7, e44543.
39. French, K. J., Upson, J. J., Keller, S. N., Zhuang, Y., Yun, J. K., and Smith, C. D. (2006) Antitumor activity of sphingosine kinase inhibitors. J. Pharmacol. Exp. Ther. 318, 596-603.
40. Allende, M. L., Sasaki, T., Kawai, H., Olivera, A., Mi, Y., van Echten-Deckert, G., Hajdu, R., Rosenbach, M., Keohane, C. A., Mandala, S., Spiegel, S., and Proia, R. L. (2004) Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J. Biol. Chem. 279, 52487-52492.
41. Dudek, S. M., Jacobson, J. R., Chiang, E. T., Birukov, K. G., Wang, P., Zhan, X., and Garcia, J. G. (2004) Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J. Biol. Chem. 279, 24692-24700.
42. Garcia, J. G., Liu, F., Verin, A. D., Birukova, A., Dechert, M. A., Gerthoffer, W. T., Bamberg, J. R., and English, D. (2001) Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J. Clin. Invest. 108, 689-701.
43. McVerry, B. J., Peng, X., Hassoun, P. M., Sammani, S., Simon, B. A., and Garcia, J. G. (2004) Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. Am. J. Respir. Crit. Care Med. 170, 987-993.
44. Peng, X., Hassoun, P. M., Sammani, S., McVerry, B. J., Burne, M. J., Rabb, H., Pearse, D., Tuder, R. M., and Garcia, J. G. (2004) Protective effects of sphingosine 1-phosphate in murine endotoxin- induced inflammatory lung injury. Am. J. Respir. Crit. Care Med. 169, 1245-1251.
45. Kharel, Y., Raje, M., Gao, M., Gellett, A. M., Tomsig, J. L., Lynch, K. R., and Santos, W. L. (2012) Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate. Biochem. J. 447, 149-157.